Clinical trialNCT02318784CompletedPhase 2Interventional

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

SponsorSCRI Development Innovations, LLCEnrollment62Neuroendocrine Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Spigel, M.D.
SCRI Development Innovations, LLC
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Rocky Mountain Cancer Center
Denver, Colorado, United States
Florida Cancer Specialists
Fort Myers, Florida, United States
Florida Hospital Cancer Institute
Orlando, Florida, United States
Florida Cancer Specialists - North
St. Petersburg, Florida, United States
Ingalls Cancer Research Center
Harvey, Illinois, United States
Research Medical Center
Kansas City, Missouri, United States
Oncology Hematology Care, Inc.
Cincinnati, Ohio, United States
Spartanburg Regional Medical Center/gibbs Cancer Center
Spartanburg, South Carolina, United States
Tennessee Oncology Pllc
Nashville, Tennessee, United States
Center for Cancer and Blood Disorders
Fort Worth, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carfilzomib →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Jul 2015
Primary completion: 15 May 2021
Completion: 15 May 2021
Last update posted: 5 Dec 2023
Registered enrollment: 62
Registry id: NCT02318784

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.